tradingkey.logo
tradingkey.logo
検索

Integra Lifesciences Holdings Corp

IART
ウォッチリストに追加
16.650USD
-0.470-2.75%
終値 07-31 16:00ET15分遅れの株価
1.29B時価総額
損失額直近12ヶ月PER

詳細情報 Integra Lifesciences Holdings Corp 企業名

Integra LifeSciences Holdings Corporation is a global medical technology company. The Company manufactures and sells medical technologies and products in two segments: Codman Specialty Surgical (CSS) and Tissue Technologies (TT). The CSS segment consists of technologies and instrumentation used for a range of specialties, such as neurosurgery, neurocritical care and otolaryngology. The CSS business consists of a portfolio of brands, such as Codman, DuraGen, DuraSeal, CUSA, Mayfield, Bactiseal, and Certas Plus, which are used for the management of multiple disease states, including brain tumors, traumatic brain injury, hydrocephalus and other neurological conditions. It provides instruments that are used in precision, specialty and general surgical procedures. The TT segment is focused on three main areas: complex wound surgery, surgical reconstruction and peripheral nerve repair. The TT segment offers skin and wound repair, plastics and surgical reconstruction products, and others.

Integra Lifesciences Holdings Corpの企業情報

企業コードIART
会社名Integra Lifesciences Holdings Corp
上場日Aug 16, 1995
最高経営責任者「CEO」Poul (Mojdeh)
従業員数4396
証券種類Ordinary Share
決算期末Aug 16
本社所在地1100 Campus Road
都市PRINCETON
証券取引所NASDAQ OMX - NASDAQ BASIC
United States of America
郵便番号08540
電話番号16092750500
ウェブサイトhttps://www.integralife.com/
企業コードIART
上場日Aug 16, 1995
最高経営責任者「CEO」Poul (Mojdeh)

Integra Lifesciences Holdings Corpの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Ms. Mojdeh Poul
Ms. Mojdeh Poul
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
102.30K
--
Mr. Christian S. (Chris) Schade
Mr. Christian S. (Chris) Schade
Independent Director
Independent Director
90.03K
--
Dr. Keith Bradley, Ph.D.
Dr. Keith Bradley, Ph.D.
Independent Director
Independent Director
88.25K
-1.00%
Ms. Lea Daniels Knight
Ms. Lea Daniels Knight
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
45.26K
-11.55%
Mr. Harvinder Singh
Mr. Harvinder Singh
Executive Vice President, President - International Business
Executive Vice President, President - International Business
35.42K
+38.07%
Mr. Jeffrey Mosebrook
Mr. Jeffrey Mosebrook
Senior Vice President - Finance, Principal Accounting Officer
Senior Vice President - Finance, Principal Accounting Officer
33.71K
-2.78%
Dr. Stuart M. Essig, Ph.D.
Dr. Stuart M. Essig, Ph.D.
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Mr. Robert T. Davis, Jr.
Mr. Robert T. Davis, Jr.
Executive Vice President, President - Tissue Technologies
Executive Vice President, President - Tissue Technologies
--
--
Ms. Barbara B. Hill
Ms. Barbara B. Hill
Independent Presiding Director
Independent Presiding Director
--
--
Mr. Eric I. Schwartz
Mr. Eric I. Schwartz
Executive Vice President, Chief Legal Officer, Secretary
Executive Vice President, Chief Legal Officer, Secretary
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Ms. Mojdeh Poul
Ms. Mojdeh Poul
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
102.30K
--
Mr. Christian S. (Chris) Schade
Mr. Christian S. (Chris) Schade
Independent Director
Independent Director
90.03K
--
Dr. Keith Bradley, Ph.D.
Dr. Keith Bradley, Ph.D.
Independent Director
Independent Director
88.25K
-1.00%
Ms. Lea Daniels Knight
Ms. Lea Daniels Knight
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
45.26K
-11.55%
Mr. Harvinder Singh
Mr. Harvinder Singh
Executive Vice President, President - International Business
Executive Vice President, President - International Business
35.42K
+38.07%
Mr. Jeffrey Mosebrook
Mr. Jeffrey Mosebrook
Senior Vice President - Finance, Principal Accounting Officer
Senior Vice President - Finance, Principal Accounting Officer
33.71K
-2.78%

よくある質問

Integra Lifesciences Holdings Corpの上位5名の株主は誰ですか?

Integra Lifesciences Holdings Corpの上位5名の株主は以下のとおりです。Ms. Mojdeh Poul

Integra Lifesciences Holdings Corp(IART)の株式を保有している機関の数はいくつですか?

2026Q1時点で、Integra Lifesciences Holdings Corpの株式を保有している機関は574社あり、保有株式の総市場価値は約82.80Mで、全体の106.43%を占めています。2025Q4と比較して、機関の持ち株は-14508057.00増加しています。

Integra Lifesciences Holdings Corpの最大の収益源は何ですか?

2026Q1において、Neurosurgery部門がIntegra Lifesciences Holdings Corpにとって最大の収益を生み出しており、その金額は827.67Mで、全収益の50.61%を占めています。
tradingkey.logo
リスク告知:当社ウェブサイト及びモバイルアプリは特定の投資商品に関する一般的な情報のみを提供しており、Finsightsは金融アドバイスや投資商品の推奨を行うものではありません。本情報の提供をもってFinsightsが投資助言を行っていると解釈されることはありません。
投資商品には元本割れを含む重大なリスクが伴い、全ての投資家に適するものではありません。なお、過去の運用実績は将来の成果を保証するものではありません。
Finsightsは、第三者広告主または提携先が当社ウェブサイト・モバイルアプリ上に広告を掲載することを許可する場合があり、これら広告主から広告への反応に基づく報酬を受けることがあります。
© 著作権: FINSIGHTS MEDIA PTE. LTD. 無断複写・転載を禁じます。